Editorial: The use of plant metabolites to ameliorate sequelae of chemotherapy
Front Pharmacol
.
2023 Nov 7:14:1320139.
doi: 10.3389/fphar.2023.1320139.
eCollection 2023.
Authors
Cijo George Vazhappilly
1
,
Shoib Sarwar Siddiqui
2
,
Ruby John Anto
3
4
,
Rajan Radhakrishnan
5
,
Naveen Kumar Devanga Ragupathi
6
7
Affiliations
1
Department of Biotechnology, School of Arts and Sciences, American University of Ras Al Khaimah, Ras Al-Khaimah, United Arab Emirates.
2
School of Life and Medical Sciences, College Lane Campus, University of Hertfordshire, Hatfield, United Kingdom.
3
Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India.
4
Molecular Bioassay Laboratory, Institute of Advanced Virology, Thiruvananthapuram, India.
5
College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
6
Department of Research and Development, Bioberrys Healthcare and Research Centre, Vellore, India.
7
Department of Chemical and Biological Engineering, The University of Sheffield, Sheffield, United Kingdom.
PMID:
38027035
PMCID:
PMC10661361
DOI:
10.3389/fphar.2023.1320139
No abstract available
Keywords:
DNA damage; cancer; chemotherapy; flavonoids; plant metabolites.
Publication types
Editorial